Northwestern University
Chicago, Illinois, United States
Purpose
to show proof of principle of the barrier properties of the synthetic mucin polymer technology (SMP) by conducting SMP efficacy studies, evaluate efficacy, invent prototype formulations, and develop technology to enrich antibody concentration
Division
Global Health
Date
July 2011
Region Served
GLOBAL
Committed amount
$575,727
Grant topic
Discovery and Translational Sciences
Duration (months)
48
Grantee location
Chicago, Illinois, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.